Sanofi

NASDAQ:SNY

Drug Manufacturers - General

Healthcare
$47.12 -0.73%

-$0.31 today

Market cap
$113.15B
Beta
0.28
P/E (TTM)
8.5
EPS (TTM)
$8.60
Dividend yield
5.62%
52W Low $41.86High $52.68

Volume 2.32M

Average 2.78M

SNY Minority Interest

The portion of consolidated subsidiaries' equity owned by outside shareholders.

SanofiNASDAQ: SNY

Minority Interest · Q2 FY2026 · quarter ended Jun 2026

Minority interest rises 32.8% from a year ago

Minority interest stood at €360M at the end of Q2 FY2026, up 32.8% from a year earlier and up 7.5% from the prior quarter. Over 3 fiscal years it compounded at -3.2% a year.

Context

  • Minority interest amounted to 0.3% of total assets at the end of Q2 FY2026, unchanged from a year earlier.
  • Minority interest increased in 1 of the last 3 fiscal years.

What to watch

Whether minority interest keeps rising in the next quarterly balance sheet after a +32.8% change from a year earlier.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterJun 2026
€360M+7.5% QoQ
Last fiscal yearDec 2025
€334M-4.6% YoY
Year agoJun 2025
€271M+32.8% since
Minority Interest past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+32.8%——
1 year-4.6%——
3-year CAGR-3.2%——
5-year CAGR——
10-year CAGR——

Minority Interest history

EUR · from the balance sheet

Latest · FY2025
334M EUR
Year-over-year change
-4.6%
4-year CAGR
-1.2%

Minority Interest vs competitors

How SNY compares with its peers on the latest reported figures

  • Peers report in different currencies, so minority interest is compared through growth and share of total assets rather than absolute size.
  • Its year-over-year change of +32.8% is the 2nd highest of 9, against a peer median of -2.4%.
  • Minority interest amounts to 0.3% of total assets for SNY, versus a peer median of 0.1%.
SNY Competitors
Minority Interest for SNY and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
NVSNovartis AGJun 2026$404M USD+485.5%+72.9%0.3%
SNYSanofiJun 2026€360M EUR+32.8%-3.2%0.3%
PFEPfizer Inc.Jun 2026$302M USD-4.7%+5.3%0.2%
AZNAstraZeneca PLCSep 2026$85.85M USD+3.4%+35.3%0.1%
MRKMerck & Co., Inc.Jun 2026$51M USD-23.9%-5.8%0.0%
LLYEli Lilly and CompanyJun 2026$0 USD-100.0%—0.0%
AMGNAmgen Inc.Jun 2026$0 USD——0.0%
NVONovo Nordisk A/SJun 2026DKK 0 DKK——0.0%
BMYBristol-Myers Squibb CompanyJun 2026$0 USD-100.0%-16.7%0.0%
GILDGilead Sciences, Inc.Jun 2026-$84M USD+0.0%—0.2%
GSKGSK plcJun 2026-£465.18M GBP+22.3%—0.8%
Peer median (excluding SNY) —-2.4%+5.3%0.1%

Competitors are the stored peer set for SNY. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

EUR
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents10.1B12.74B8.71B7.44B7.66B
Short-term Investments000486M810M
Net Receivables9.79B10.75B11.04B10.63B11.05B
Inventory8.72B8.96B9.67B9.43B10.21B
Other Current Assets1.35B870M471M13.71B307M
Total Current Assets30.56B34.03B30.66B42.59B30.95B
Property, Plant & Equipment (Net)11.98B11.68B11.81B11.6B11.51B
Goodwill48.06B49.89B49.4B43.38B41.3B
Intangible Assets21.41B21.64B24.32B22.63B26.26B
Long-term Investments2.91B3.22B3.26B3.26B6.61B
Tax Assets4.6B5.38B6.43B7.97B8.61B
Other Non-current Assets731M882M588M1.37B1.56B
Total Non-current Assets89.68B92.7B95.81B90.21B95.85B
Total Assets120.24B126.72B126.46B132.8B126.81B
Account Payables6.18B6.81B7.33B7.55B7.36B
Short-term Debt3.45B4.45B2.32B4.21B4.34B
Tax Payables309M574M597M1.13B0
Deferred Revenue319M264M000
Other Current Liabilities10.61B11.86B11.57B15.13B14.69B
Total Current Liabilities21.3B23.96B24.19B29.16B28.35B
Long-term Debt17.12B14.86B14.35B11.79B14.25B
Deferred Tax Liabilities1.62B1.84B1.86B2.17B1.67B
Deferred Revenue (Non-current)00000
Other Non-current Liabilities9.34B9B9.96B10.18B9.37B
Total Non-current Liabilities29.92B27.61B27.92B25.78B26.75B
Total Liabilities51.21B51.57B52.11B54.94B55.1B
Common Stock2.53B2.52B2.53B2.53B2.44B
Retained Earnings63.01B66.73B67.5B00
Accumulated OCI3.55B6.11B4.88B70.56B64.44B
Other Stockholders Equity0005.26B5.57B
Minority Interest350M368M313M350M334M
Total Equity69.03B75.15B74.35B77.86B71.71B
Total Debt22.41B21.21B18.7B17.91B20.33B
Net Debt12.32B8.48B9.99B10.47B12.67B

Sanofi

NASDAQ:SNY

Intrinsic Alpha fair value

Locked

Current Price

$47.12

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.